Effect of keishibukuryogan on genetic and dietary obesity models

Evidence-based Complementary and Alternative Medicine : ECAM
Fengying GaoYoshihiro Hayakawa

Abstract

Obesity has been recognized as one of the most important risk factors for a variety of chronic diseases, such as diabetes, hypertension/cardiovascular diseases, steatosis/hepatitis, and cancer. Keishibukuryogan (KBG, Gui Zhi Fu Ling Wan in Chinese) is a traditional Chinese/Japanese (Kampo) medicine that has been known to improve blood circulation and is also known for its anti-inflammatory or scavenging effect. In this study, we evaluated the effect of KBG in two distinct rodent models of obesity driven by either a genetic (SHR/NDmcr-cp rat model) or dietary (high-fat diet-induced mouse obesity model) mechanism. Although there was no significant effect on the body composition in either the SHR rat or the DIO mouse models, KBG treatment significantly decreased the serum level of leptin and liver TG level in the DIO mouse, but not in the SHR rat model. Furthermore, a lower fat deposition in liver and a smaller size of adipocytes in white adipose tissue were observed in the DIO mice treated with KBG. Importantly, we further found downregulation of genes involved in lipid metabolism in the KBG-treated liver, along with decreased liver TG and cholesterol level. Our present data experimentally support in fact that KBG can be an attra...Continue Reading

References

Feb 1, 1997·Biochimie·B M SpiegelmanR Brun
Apr 9, 2004·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·H GotoK Terasawa
Nov 25, 2006·Journal of Ethnopharmacology·Takako NakagawaYutaka Shimada
Feb 26, 2008·Experimental Biology and Medicine·Makoto FujimotoYutaka Shimada
May 17, 2011·Annual Review of Nutrition·Dale E BaumanAdam L Lock
May 26, 2011·Journal of Molecular Endocrinology·Loes P M DuivenvoordeJaap Keijer
Jan 3, 2013·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·A ZhangX Wang
Sep 18, 2014·World Journal of Cardiology·Daisuke Usuda, Tsugiyasu Kanda
Oct 12, 2014·Metabolism: Clinical and Experimental·Heike Münzberg, Christopher D Morrison

❮ Previous
Next ❯

Citations

Jan 16, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Ziyu ZhangOuping Huang

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
ELISA
PCR

Software Mentioned

JMP

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Related Papers

Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición
Rocío Guzmán-RuizMariano Ruiz-Gayo
Proceedings of the National Science Council, Republic of China. Part B, Life Sciences
W H LinE Lin
© 2021 Meta ULC. All rights reserved